Persisting local variations in prevalence of hepatitis C virus among Scottish problem drug users: Results from an anonymous screening study

Drugs: Education, Prevention and Policy

Volumn 13, Issue 2, 2006, Pages 189-191

  Bloor, Michael ^a   Neale, Joanne ^b   McKeganey, Neil ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Hepatitis C virus; Injecting drug use; Scotland

Indexed keywords

EID: 33646933861     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.1080/09687630500468553     Document Type: Article

References (5)

1. Bird, S., Goldberg, D., & Hutchinson, S. (2001). Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection. Journal of Epidemiology & Biostatistics, 6, 267-277.
2. Codere, G., Shaw, L., & Goldberg, D. (2004). Surveillance of known hepatitis C antibody positive cases in Scotland: Results to 31 December 2003. SCIEH Weekly Report, 38, 150-151.
3. Hay, G., Gannon, M., McKeganey, N., Hutchinson, S., & Goldberg, D. (2005). Estimating the national and local prevalence of problem drug use in Scotland. Centre for Drug Misuse Research & Health Protection Scotland. (Available at: www.drugmisuse.isdscotland.org.uk)
4. Neale, J., & Robertson, M. (2005). Recent life problems and non-fatal overdose among heroin users entering treatment. Addiction, 100, 168-175.
5. Royal college of physicians of Edinburgh. (2004). Consensus statement on hepatitis C. Journal of Viral Hepatitis, 11(Suppl. 1), 2-4.